Other mechanisms implicated in the renoprotection of myricetin include the upregulation of Nrf2/HO‐1 (Berkoz et al. 2024) and induction of M2 macrophage polarization to impede renal tubulointerstitial fibrosis in DKD through PI3K/AKT (Xu et al. 2024). Here, HMOX1 is linked to diabetic kidney disease.